Treatment Arm

Visit number vs Plasminogen activator inhibitor-1 (PAI-1)
N Mean StdDev Median Min Max Unknown Total
Baseline Visit 164 6.6 ± 4.7 5.1 0.7 23.0 5 169
Month-6 Follow-up Visit 110 6.9 ± 5.2 5.5 0.9 27.6 59 169
Month-12 Follow-up Visit 80 6.8 ± 6.2 4.8 0.8 37.0 28 108
Treatment arm vs Plasminogen activator inhibitor-1 (PAI-1)
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 164 6.6 ± 4.7 5.1 0.7 23.0 5 169
Conservative Medical Therapy (CMT) 43 6.3 ± 4.4 4.0 1.7 18.9 1 44
CMT + Sham CPAP 41 6.2 ± 4.9 5.5 0.7 19.9 1 42
CMT + Active CPAP 41 6.6 ± 4.4 5.1 0.9 17.1 1 42
CMT + Active CPAP + Motivational Enhancement 39 7.6 ± 5.1 6.2 1.9 23.0 2 41
Treatment arm vs Plasminogen activator inhibitor-1 (PAI-1)
Month-6 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 110 6.9 ± 5.2 5.5 0.9 27.6 59 169
Conservative Medical Therapy (CMT) 29 7.2 ± 4.5 6.1 1.6 14.8 15 44
CMT + Sham CPAP 28 5.6 ± 4.1 4.1 0.9 17.5 14 42
CMT + Active CPAP 28 7.4 ± 5.9 5.2 0.9 18.8 14 42
CMT + Active CPAP + Motivational Enhancement 25 7.6 ± 6.1 6.4 1.0 27.6 16 41
Treatment arm vs Plasminogen activator inhibitor-1 (PAI-1)
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 80 6.8 ± 6.2 4.8 0.8 37.0 28 108
Conservative Medical Therapy (CMT) 23 7.1 ± 5.5 4.8 0.8 18.2 6 29
CMT + Sham CPAP 21 5.1 ± 4.2 4.1 1.4 17.0 6 27
CMT + Active CPAP 18 8.6 ± 9.4 5.4 1.9 37.0 8 26
CMT + Active CPAP + Motivational Enhancement 18 6.7 ± 4.8 6.6 0.9 16.0 8 26
Age at visit vs Plasminogen activator inhibitor-1 (PAI-1)
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 164 6.6 ± 4.7 5.1 0.7 23.0 5 169
46.0 to 59.0 years 42 6.9 ± 5.4 5.4 0.7 23.0 1 43
59.0 to 66.0 years 40 7.9 ± 4.6 7.2 1.6 18.2 2 42
66.0 to 69.0 years 42 6.9 ± 4.7 5.3 1.0 18.9 - 42
70.0 to 76.0 years 40 4.9 ± 3.5 3.8 1.0 15.0 2 42
Age at visit vs Plasminogen activator inhibitor-1 (PAI-1)
Month-6 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 110 6.9 ± 5.2 5.5 0.9 27.6 59 169
46.0 to 60.0 years 20 7.9 ± 6.6 6.5 1.7 27.6 23 43
60.0 to 66.0 years 30 7.4 ± 5.6 5.5 1.0 18.6 12 42
66.0 to 70.0 years 30 6.9 ± 4.3 5.7 0.9 17.5 12 42
70.0 to 77.0 years 30 5.7 ± 4.4 4.9 0.9 16.9 12 42
Age at visit vs Plasminogen activator inhibitor-1 (PAI-1)
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 80 6.8 ± 6.2 4.8 0.8 37.0 28 108
47.0 to 60.0 years 16 6.8 ± 4.9 4.9 1.9 16.7 11 27
60.0 to 66.0 years 21 7.0 ± 5.5 4.1 1.8 17.0 6 27
66.0 to 70.0 years 21 8.7 ± 8.7 6.7 1.1 37.0 6 27
71.0 to 77.0 years 22 5.0 ± 4.4 4.5 0.8 18.2 5 27
Gender vs Plasminogen activator inhibitor-1 (PAI-1)
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 164 6.6 ± 4.7 5.1 0.7 23.0 5 169
Male 107 6.2 ± 4.6 4.6 0.9 23.0 3 110
Female 57 7.5 ± 4.7 6.7 0.7 18.9 2 59
Gender vs Plasminogen activator inhibitor-1 (PAI-1)
Month-6 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 110 6.9 ± 5.2 5.5 0.9 27.6 59 169
Male 78 6.3 ± 4.5 5.4 0.9 18.8 32 110
Female 32 8.3 ± 6.4 6.0 0.9 27.6 27 59
Gender vs Plasminogen activator inhibitor-1 (PAI-1)
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 80 6.8 ± 6.2 4.8 0.8 37.0 28 108
Male 53 6.9 ± 6.3 5.1 0.8 37.0 19 72
Female 27 6.8 ± 6.1 4.6 1.6 27.2 9 36
Race vs Plasminogen activator inhibitor-1 (PAI-1)
Baseline Visit
N Mean StdDev Median Min Max Unknown Total
Total 163 6.6 ± 4.7 5.1 0.7 23.0 5 168
White 148 6.8 ± 4.8 5.1 0.7 23.0 4 152
American Indian or Alaskan Native - - - - - - - -
Black or African American 10 5.4 ± 2.8 5.5 0.9 9.7 1 11
Asian 4 5.5 ± 5.4 3.7 1.5 13.2 - 4
Native Hawaiian or other Pacific islander - - - - - - - -
Other 1 3.8 - 3.8 3.8 3.8 - 1
Multiple - - - - - - - -
Race vs Plasminogen activator inhibitor-1 (PAI-1)
Month-6 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 109 6.9 ± 5.2 5.4 0.9 27.6 59 168
White 102 7.0 ± 5.3 5.4 0.9 27.6 50 152
American Indian or Alaskan Native - - - - - - - -
Black or African American 5 4.8 ± 2.3 3.5 2.7 7.2 6 11
Asian 2 9.4 ± 5.3 9.4 5.7 13.2 2 4
Native Hawaiian or other Pacific islander - - - - - - - -
Other - - - - - - 1 1
Multiple - - - - - - - -
Race vs Plasminogen activator inhibitor-1 (PAI-1)
Month-12 Follow-up Visit
N Mean StdDev Median Min Max Unknown Total
Total 80 6.8 ± 6.2 4.8 0.8 37.0 28 108
White 73 7.0 ± 6.4 5.1 0.8 37.0 22 95
American Indian or Alaskan Native - - - - - - - -
Black or African American 5 5.5 ± 2.8 4.6 3.5 10.5 4 9
Asian 2 3.2 ± 0.4 3.2 2.9 3.5 1 3
Native Hawaiian or other Pacific islander - - - - - - - -
Other - - - - - - 1 1
Multiple - - - - - - - -